Clinical Infectious Diseases

Traditionally, we've used a very pathogen-specific approach. We're combining multiple PCR tests in one platform known as a syndromic panel. It can be DNA targets and RNA targets combined. And basically instead of saying you have to have a clinical suspicion of is this HSB yes or no, you can just say I'm concerned my patient has a central nervous system infection. That's still a really interesting area of inquiry. How do they change how we practice medicine day to day?